Skip to content

Development of probiotic formula for remission of metabolic syndrome

Study for the alleviation effect of probiotics compound formula for metabolic syndrome

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900021570
Enrollment
Unknown
Registered
2019-02-27
Start date
2018-10-01
Completion date
Unknown
Last updated
2019-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Metabolic syndrome

Interventions

Control group: Placebo
Intervention group: Probiotics
Intervention group:Probiotics and polysaccharides

Sponsors

Yancheng Sixth People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Comply with MS diagnosis; 2. 30 years old = age = 50 years old, male or female; 3. Compliance is good, and can comply with the requirements of clinical trials; 4. the subject or guardian has signed an informed consent form; 5. The patient fills out a written informed consent form, a basic situation questionnaire, a dietary structure and a living status questionnaire, and commits to cooperate with the study throughout the experiment; 6. Pre-treatment urine, stool routine, liver and kidney function tests are in the normal range.

Exclusion criteria

Exclusion criteria: 1. known to be allergic to any component of the test drug; 2. a smoker; 3. those who have recently lost weight significantly or who are involved in weight loss programs; 4. The patient refuses to sign an informed consent form, or estimates poor adherence and poor follow-up; 5. in menopause, pregnancy or lactation; 6. Patients with type 1 diabetes, patients with type 2 diabetes who have been injected with insulin, patients with hemoglobin A1c > 9%, and patients with significant liver function tests (alanine aminotransferase = 3 times normal upper limit), significant renal impairment ( Patients with plasma creatinine >150 µmmol / l); taking in hypoglycemic, lipid-lowering or antihypertensive drugs; 7. taking probiotic products or long-term consumption of yogurt and probiotic beverages in the near future (1-3 months); 8. recent (1-3 months) or long-term use of antibiotics; 9. allergic or intolerant to the ingredients of the experimental probiotic product; 10. Other cases that do not meet the inclusion criteria.

Design outcomes

Primary

MeasureTime frame
blood pressure;Blood lipid;blood sugar;body weight;waistline;Hip circumference;

Countries

China

Contacts

Public ContactGang Wang

Jiangnan University School of Food

wanggang@jiangnan.edu.cn+86 15852818722

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026